People whose blood tests looked "older" than their age were more likely to have a narrowed heart valve

In a Chinese hospital study and a large US community study, people whose routine clinical measurements pointed to a higher biological age had higher odds of aortic valve stenosis, a stiff, narrowed heart valve. A genetic analysis hinted at cause and effect for one of the two measures, but not the other. The studies are observational.

The aortic valve is the door between the heart's main pumping chamber and the aorta, the large artery that carries blood to the body. With age, its thin flaps can thicken and harden with calcium deposits, so the valve no longer opens fully. This is called aortic valve stenosis. It is the most common heart valve disease in the world, often gives no symptoms in its milder stages, and no drug can reverse it.

Age is the strongest known risk factor. But people of the same age can be at very different stages of wear. That is the idea behind biological age: an estimate of how old the body "looks" from a set of health measurements. A team at Sun Yat-Sen University in Guangzhou, China, asked whether people whose biological age ran ahead of their real age were more likely to have a narrowed aortic valve. In two groups of people, they were. Because the studies are observational, they show a link, not a cause.

What they did

The team used two very different groups:

  • 4,526 hospital patients in Guangzhou with conditions such as high blood pressure, diabetes or heart disease (average age 61), of whom 113 had aortic valve stenosis.
  • 5,114 participants of a US community study (ARIC) who had blood tests and other measurements in midlife, at an average age of 52, in the late 1980s. About two decades later, they had a heart ultrasound; 266 had a narrowed valve.

From routine measurements such as blood pressure, blood fats, blood sugar, kidney and blood-count values (13 measurements in the Chinese group, 8 in the American one), the team calculated each person's biological age with two established methods, called KDM and PhenoAge. The gap between biological and real age is the age acceleration: a positive gap means the body looks older than its years.

They then compared the odds of valve stenosis, taking into account age, sex, high blood pressure, diabetes, coronary heart disease, several medicines and, in the US group, race, smoking and drinking. Finally, they ran a Mendelian randomization analysis, which uses natural genetic variation to test whether a link is likely to be causal.

What they found

  • Faster biological aging went with higher odds of a narrowed valve, in both groups and with both methods. For each step up in age acceleration (one standard deviation, a unit of spread), the odds were 29% to 48% higher in the Chinese patients and 30% to 42% higher in the US group.
  • The quarter of people who were aging fastest had roughly twice the odds of those aging slowest (odds ratios between 1.95 and 2.64, depending on the group and method).
  • The link was also seen for moderate to severe stenosis, not just mild cases.
  • In the US group, the measurements came about 20 years before the ultrasound, which suggests that faster biological aging in midlife goes with valve disease in later life.
  • The genetic analysis was mixed. Genetic variants linked to faster aging by the KDM method were linked to a higher risk of valve stenosis (odds ratio 1.38), which the team reads as a possible causal link. For PhenoAge, there was no such link.

What to keep in mind

  • Association, not proof of cause. The authors note that hidden factors could still explain part of the link, and the two genetic analyses pointed in different directions.
  • Biological age is built partly from known heart risk factors such as blood pressure, blood sugar and cholesterol. The authors themselves suggest that these may drive much of the link.
  • The Chinese group were hospital patients, so mild cases, which rarely bring people to hospital, were probably under-counted. The authors say this may have introduced bias, and that the results may not apply to healthy older people.
  • In the US group, the heart ultrasound was done only once, at the end, so the team could not tell when the valve problem began. Many of the original participants were left out because they had no ultrasound data from that later visit.
  • Only a limited set of routine tests was available to estimate biological age, and the two groups used different sets.
  • The study looked only at whether people had the disease, not at how it progressed.

Why it matters

No drug can yet reverse aortic valve stenosis, so finding people at high risk early matters. This study suggests that a biological age worked out from ordinary clinical tests might add something to age and classic risk factors when judging who is at risk. It does not show that lowering one's biological age would protect the valve. The authors call for confirmation in other groups of people and for work on the underlying biology, especially inflammation and blood fats.